Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL HEMATOLOGY ANALYZERS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL HEMATOLOGY ANALYZERS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 SALES VOLUME DATA
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL HEMATOLOGY ANALYZERS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 EPIDEMIOLOGY
5.1 ANEMIA
5.2 BLOOD CANCERS
6 PREMIUM INSIGHTS
6.1 PESTEL ANALYSIS
6.2 PORTER’S 5 FORCES MODEL
6.3 REGULATORY FRAMWORK
7 INDUSTRY INSIGHTS
8 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 CBC ANALYZERS
8.2.1 3-PART DIFFERENTIAL CELL COUNTER
8.2.1.1. MARKET VALUE (USD MILLION)
8.2.1.2. MARKET VOLUME (UNITS)
8.2.1.3. AVERAGE SELLING PRICE (USD)
8.2.2 5-PART DIFFERENTIAL CELL COUNTER
8.2.2.1. MARKET VALUE (USD MILLION)
8.2.2.2. MARKET VOLUME (UNITS)
8.2.2.3. AVERAGE SELLING PRICE (USD)
8.2.3 POINT OF CARE
8.2.3.1. HEMOGLOBIN METER
8.2.3.1.1. MARKET VALUE (USD MILLION)
8.2.3.1.2. MARKET VOLUME (UNITS)
8.2.3.1.3. AVERAGE SELLING PRICE (USD)
8.2.3.2. RYTHROCYTE SEDIMENTATION (ESR) INSTRUMENT
8.2.3.2.1. MARKET VALUE (USD MILLION)
8.2.3.2.2. MARKET VOLUME (UNITS)
8.2.3.2.3. AVERAGE SELLING PRICE (USD)
8.2.3.3. HEMATOCRIT MEASUREMENT
8.2.3.3.1. MARKET VALUE (USD MILLION)
8.2.3.3.2. MARKET VOLUME (UNITS)
8.2.3.3.3. AVERAGE SELLING PRICE (USD)
8.2.4 OTHERS
8.3 PBS ANALYZERS
8.3.1 MANUAL PBS ANALYZERS
8.3.2 SEMI-AUTOMATED PBS ANALYZERS
8.3.3 FULLY AUTOMATED PBS ANALYZERS
9 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY FEATURES
9.1 OVERVIEW
9.2 TOUCHSCREEN
9.3 AUTO-SAMPLER
9.4 CRP ANALYZER
9.5 CAP-PIERCING SYSTEM
9.6 COMPUTER ASSISTED
9.7 OTHERS
10 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY VOLUME
10.1 OVERVIEW
10.2 LOW VOLUME
10.3 MID VOLUME
10.4 HIGH VOLUME
11 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY CONFIGURATION
11.1 OVERVIEW
11.2 BENCHTOP
11.3 INTEGRATED SYSTEM
11.4 COMPACT
12 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY TECHNOLOGY
12.1 OVERVIEW
12.2 FLOW CYTOMETRY
12.3 SPECTROPHOTOMETRY
12.4 ELECTRICAL IMPEDANCE
12.5 OPTICAL DETECTION
12.6 MICROFLUIDICS TECHNOLOGY
12.7 OTHERS
13 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY APPLICATIONS
13.1 OVERVIEW
13.2 CLINICAL TESTING
13.2.1 ROUTINE BLOOD TESTS
13.2.2 HEMOGLOBINOPATHY TESTING
13.2.3 LEUKEMIA AND LYMPHOMA TESTING
13.2.4 SEPSIS AND INFECTIONS DIAGNOSIS
13.3 RESEARCH APPLICATIONS
13.3.1 DISEASE DIAGNOSIS RESEARCH
13.3.2 DRUG DEVELOPMENT
13.3.3 GENETIC RESEARCH
13.4 OTHERS
14 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY END USER
14.1 OVERVIEW
14.2 HOSPITALS
14.3 SPECIALTY CLINICS
14.4 LABORATORIES
14.5 ACADEMIC & RESEARCH INSTITUTES
14.6 OTHERS
15 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDER
15.3 RETAIL SALES
15.3.1 ONLINE
15.3.2 OFFLINE
15.4 OTHERS
16 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY REGION
GLOBAL HEMATOLOGY ANALYZERS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
16.1.1 NORTH AMERICA
16.1.1.1. U.S.
16.1.1.2. CANADA
16.1.1.3. MEXICO
16.1.2 EUROPE
16.1.2.1. GERMANY
16.1.2.2. FRANCE
16.1.2.3. U.K.
16.1.2.4. ITALY
16.1.2.5. SPAIN
16.1.2.6. RUSSIA
16.1.2.7. TURKEY
16.1.2.8. BELGIUM
16.1.2.9. NETHERLANDS
16.1.2.10. SWITZERLAND
16.1.2.11. REST OF EUROPE
16.1.3 ASIA-PACIFIC
16.1.3.1. JAPAN
16.1.3.2. CHINA
16.1.3.3. SOUTH KOREA
16.1.3.4. INDIA
16.1.3.5. AUSTRALIA
16.1.3.6. SINGAPORE
16.1.3.7. THAILAND
16.1.3.8. MALAYSIA
16.1.3.9. INDONESIA
16.1.3.10. PHILIPPINES
16.1.3.11. REST OF ASIA-PACIFIC
16.1.4 SOUTH AMERICA
16.1.4.1. BRAZIL
16.1.4.2. ARGENTINA
16.1.4.3. REST OF SOUTH AMERICA
16.1.5 MIDDLE EAST AND AFRICA
16.1.5.1. SOUTH AFRICA
16.1.5.2. SAUDI ARABIA
16.1.5.3. UAE
16.1.5.4. EGYPT
16.1.5.5. ISRAEL
16.1.5.6. REST OF MIDDLE EAST AND AFRICA
16.1.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
17 GLOBAL HEMATOLOGY ANALYZERS MARKET, COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: GLOBAL
17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
17.3 COMPANY SHARE ANALYSIS: EUROPE
17.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
17.5 MERGERS & ACQUISITIONS
17.6 NEW PRODUCT DEVELOPMENT & APPROVALS
17.7 EXPANSIONS
17.8 REGULATORY CHANGES
17.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
18 GLOBAL HEMATOLOGY ANALYZERS MARKET, SWOT AND DBMR ANALYSIS
19 GLOBAL HEMATOLOGY ANALYZERS MARKET, COMPANY PROFILE
19.1 BECKMAN COULTER, INC.
19.1.1 COMPANY OVERVIEW
19.1.2 REVENUE ANALYSIS
19.1.3 GEOGRAPHIC PRESENCE
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENTS
19.2 SIEMENS HEALTHCARE PRIVATE LIMITED
19.2.1 COMPANY OVERVIEW
19.2.2 REVENUE ANALYSIS
19.2.3 GEOGRAPHIC PRESENCE
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENTS
19.3 SYSMEX
19.3.1 COMPANY OVERVIEW
19.3.2 REVENUE ANALYSIS
19.3.3 GEOGRAPHIC PRESENCE
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENTS
19.4 CLINICAL DIAGNOSTIC SOLUTIONS, INC.
19.4.1 COMPANY OVERVIEW
19.4.2 REVENUE ANALYSIS
19.4.3 GEOGRAPHIC PRESENCE
19.4.4 PRODUCT PORTFOLIO
19.4.5 RECENT DEVELOPMENTS
19.5 ABBOTT
19.5.1 COMPANY OVERVIEW
19.5.2 REVENUE ANALYSIS
19.5.3 GEOGRAPHIC PRESENCE
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT DEVELOPMENTS
19.6 TRIVITRON HEALTHCARE
19.6.1 COMPANY OVERVIEW
19.6.2 REVENUE ANALYSIS
19.6.3 GEOGRAPHIC PRESENCE
19.6.4 PRODUCT PORTFOLIO
19.6.5 RECENT DEVELOPMENTS
19.7 BIO-RAD LABORATORIES, INC.
19.7.1 COMPANY OVERVIEW
19.7.2 REVENUE ANALYSIS
19.7.3 GEOGRAPHIC PRESENCE
19.7.4 PRODUCT PORTFOLIO
19.7.5 RECENT DEVELOPMENTS
19.8 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
19.8.1 COMPANY OVERVIEW
19.8.2 REVENUE ANALYSIS
19.8.3 GEOGRAPHIC PRESENCE
19.8.4 PRODUCT PORTFOLIO
19.8.5 RECENT DEVELOPEMENTS
19.9 ERBA GROUP
19.9.1 COMPANY OVERVIEW
19.9.2 REVENUE ANALYSIS
19.9.3 GEOGRAPHIC PRESENCE
19.9.4 PRODUCT PORTFOLIO
19.9.5 RECENT DEVELOPEMENTS
19.1 ABAXIS
19.10.1 COMPANY OVERVIEW
19.10.2 REVENUE ANALYSIS
19.10.3 GEOGRAPHIC PRESENCE
19.10.4 PRODUCT PORTFOLIO
19.10.5 RECENT DEVELOPEMENTS
19.11 IDEXX LABORATORIES, INC.
19.11.1 COMPANY OVERVIEW
19.11.2 REVENUE ANALYSIS
19.11.3 GEOGRAPHIC PRESENCE
19.11.4 PRODUCT PORTFOLIO
19.11.5 RECENT DEVELOPEMENTS
19.12 ATHENESE INC.
19.12.1 COMPANY OVERVIEW
19.12.2 REVENUE ANALYSIS
19.12.3 GEOGRAPHIC PRESENCE
19.12.4 PRODUCT PORTFOLIO
19.12.5 RECENT DEVELOPEMENTS
19.13 DRUCKER DIAGNOSTICS
19.13.1 COMPANY OVERVIEW
19.13.2 REVENUE ANALYSIS
19.13.3 GEOGRAPHIC PRESENCE
19.13.4 PRODUCT PORTFOLIO
19.13.5 RECENT DEVELOPMENTS
19.14 SIGHT DIAGNOSTICS
19.14.1 COMPANY OVERVIEW
19.14.2 REVENUE ANALYSIS
19.14.3 GEOGRAPHIC PRESENCE
19.14.4 PRODUCT PORTFOLIO
19.14.5 RECENT DEVELOPMENTS
19.15 TECO DIAGNOSTICS
19.15.1 COMPANY OVERVIEW
19.15.2 REVENUE ANALYSIS
19.15.3 GEOGRAPHIC PRESENCE
19.15.4 PRODUCT PORTFOLIO
19.15.5 RECENT DEVELOPMENTS
19.16 HORIBA MEDICAL
19.16.1 COMPANY OVERVIEW
19.16.2 REVENUE ANALYSIS
19.16.3 GEOGRAPHIC PRESENCE
19.16.4 PRODUCT PORTFOLIO
19.16.5 RECENT DEVELOPMENTS
19.17 MINDRAY MEDICAL INTERNATIONAL LIMITED
19.17.1 COMPANY OVERVIEW
19.17.2 REVENUE ANALYSIS
19.17.3 GEOGRAPHIC PRESENCE
19.17.4 PRODUCT PORTFOLIO
19.17.5 RECENT DEVELOPMENTS
19.18 DIATRON GROUP
19.18.1 COMPANY OVERVIEW
19.18.2 REVENUE ANALYSIS
19.18.3 GEOGRAPHIC PRESENCE
19.18.4 PRODUCT PORTFOLIO
19.18.5 RECENT DEVELOPMENTS
19.19 NIHON KOHDEN CORPORATION
19.19.1 COMPANY OVERVIEW
19.19.2 REVENUE ANALYSIS
19.19.3 GEOGRAPHIC PRESENCE
19.19.4 PRODUCT PORTFOLIO
19.19.5 RECENT DEVELOPMENTS
19.2 BOULE DIAGNOSTICS AB
19.20.1 COMPANY OVERVIEW
19.20.2 REVENUE ANALYSIS
19.20.3 GEOGRAPHIC PRESENCE
19.20.4 PRODUCT PORTFOLIO
19.20.5 RECENT DEVELOPMENTS
19.21 DREW SCIENTIFIC GROUP
19.21.1 COMPANY OVERVIEW
19.21.2 REVENUE ANALYSIS
19.21.3 GEOGRAPHIC PRESENCE
19.21.4 PRODUCT PORTFOLIO
19.21.5 RECENT DEVELOPMENTS
19.22 BIOSYSTEMS S.A
19.22.1 COMPANY OVERVIEW
19.22.2 REVENUE ANALYSIS
19.22.3 GEOGRAPHIC PRESENCE
19.22.4 PRODUCT PORTFOLIO
19.22.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
20 RELATED REPORTS
21 CONCLUSION
22 QUESTIONNAIRE
23 ABOUT DATA BRIDGE MARKET RESEARCH
